Reduction of thromboembolic complications during the endovascular treatment of unruptured aneurysms by employing a tailored dual antiplatelet regimen using …

S Higashiguchi, A Sadato, I Nakahara… - Journal of …, 2021 - jnis.bmj.com
Background Thromboembolic complications (TECs) are frequent during the endovascular
treatment of unruptured aneurysms. To prevent TECs, dual antiplatelet therapy using aspirin …

[PDF][PDF] Reduction of thromboembolic complications during the endovascular treatment of unruptured aneurysms by employing a tailored dual antiplatelet regimen …

S Higashiguchi, A Sadato, I Nakahara, S Matsumoto… - researchgate.net
ABSTRACT Background Thromboembolic complications (TECs) are frequent during the
endovascular treatment of unruptured aneurysms. To prevent TECs, dual antiplatelet …

Reduction of thromboembolic complications during the endovascular treatment of unruptured aneurysms by employing a tailored dual antiplatelet regimen using …

S Higashiguchi, A Sadato, I Nakahara… - Journal of …, 2021 - europepmc.org
Background Thromboembolic complications (TECs) are frequent during the endovascular
treatment of unruptured aneurysms. To prevent TECs, dual antiplatelet therapy using aspirin …

[PDF][PDF] Reduction of thromboembolic complications during the endovascular treatment of unruptured aneurysms by employing a tailored dual antiplatelet regimen …

S Higashiguchi, A Sadato, I Nakahara… - Journal of …, 2021 - jnis.bmj.com
Background Thromboembolic complications (TECs) are frequent during the endovascular
treatment of unruptured aneurysms. To prevent TECs, dual antiplatelet therapy using aspirin …

[PDF][PDF] Reduction of thromboembolic complications during the endovascular treatment of unruptured aneurysms by employing a tailored dual antiplatelet regimen …

S Higashiguchi, A Sadato, I Nakahara, S Matsumoto… - scholar.archive.org
ABSTRACT Background Thromboembolic complications (TECs) are frequent during the
endovascular treatment of unruptured aneurysms. To prevent TECs, dual antiplatelet …

Reduction of thromboembolic complications during the endovascular treatment of unruptured aneurysms by employing a tailored dual antiplatelet regimen using …

S Higashiguchi, A Sadato… - Journal of …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Thromboembolic complications (TECs) are frequent during the endovascular
treatment of unruptured aneurysms. To prevent TECs, dual antiplatelet therapy using aspirin …

Reduction of thromboembolic complications during the endovascular treatment of unruptured aneurysms by employing a tailored dual antiplatelet regimen using …

S Higashiguchi, A Sadato, I Nakahara… - Journal of …, 2021 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Background</jats: title>< jats: p> Thromboembolic complications
(TECs) are frequent during the endovascular treatment of unruptured aneurysms. To prevent …

[HTML][HTML] Reduction of thromboembolic complications during the endovascular treatment of unruptured aneurysms by employing a tailored dual antiplatelet regimen …

S Higashiguchi, A Sadato, I Nakahara… - Journal of …, 2021 - ncbi.nlm.nih.gov
Background Thromboembolic complications (TECs) are frequent during the endovascular
treatment of unruptured aneurysms. To prevent TECs, dual antiplatelet therapy using aspirin …

Reduction of thromboembolic complications during the endovascular treatment of unruptured aneurysms by employing a tailored dual antiplatelet regimen using …

S Higashiguchi, A Sadato, I Nakahara… - Journal of …, 2021 - pure.fujita-hu.ac.jp
Background Thromboembolic complications (TECs) are frequent during the endovascular
treatment of unruptured aneurysms. To prevent TECs, dual antiplatele therapy using aspirin …

Reduction of thromboembolic complications during the endovascular treatment of unruptured aneurysms by employing a tailored dual antiplatelet regimen using …

S Higashiguchi, A Sadato, I Nakahara… - Journal of …, 2021 - pure.fujita-hu.ac.jp
Background Thromboembolic complications (TECs) are frequent during the endovascular
treatment of unruptured aneurysms. To prevent TECs, dual antiplatele therapy using aspirin …